Invesco IVZ Investments and other assets of consolidated investment products (CIP)
Investments and other assets of consolidated investment products (CIP) at other companies
Other financials
Where this comes from
Reported directly by Invesco in its filing.
Tagged under the XBRL concept ivz:InvestmentsAndOtherAssetsOfVariableInterestEntities.
The official record: Invesco’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Invesco's investments and other assets of consolidated investment products (cip).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Invesco's investments and other assets of consolidated investment products (CIP)?
- Invesco (IVZ) reported investments and other assets of consolidated investment products (CIP) of $10.13B in Q1 2026.
- How has Invesco's investments and other assets of consolidated investment products (CIP) changed year-over-year?
- Invesco's investments and other assets of consolidated investment products (CIP) increased by 5.3% year-over-year, from $9.62B to $10.13B.
- What is the long-term trend for Invesco's investments and other assets of consolidated investment products (CIP)?
- Over 2 years (2023 to 2025), Invesco's investments and other assets of consolidated investment products (CIP) has grown at a 3.5% compound annual growth rate (CAGR), from $9.48B to $10.15B.
- What does investments and other assets of consolidated investment products (CIP) mean?
- Long-term assets belonging to investment funds that the company is required to consolidate for accounting purposes.
- How do you interpret investments and other assets of consolidated investment products (CIP)?
- Changes reflect the performance and size of consolidated investment vehicles rather than the firm's own operational health.
- How does investments and other assets of consolidated investment products (CIP) compare across companies?
- Specific to asset managers with consolidated fund structures; peers with similar accounting treatments will show similar volatility.